Safety signal alerts from Pharmacovigilance Programme of India
The National Coordination Centre – Pharmacovigilance Programme of India (NCC-PvPI) has made a recommendation to the Central Drugs Standard Control Organisation (CDSCO) to request that the patient information leaflet (PIL) for cardiac drug pentoxifylline, hypertension drug benidipine, respiratory infection drug piperacillin/tazobactum, enlarged-prostate drug alfuzosin and tinidazole should be revised to …